ALX Oncology Holdings Inc. (ALXO) Quarterly Cash Flow Statement

120+ quarters historyFree accessUpdated daily

ALX Oncology Holdings Inc. (ALXO) quarterly cash flow statement — complete operating, investing & financing history

Quarterly statement

ALXO Cash Flow Statement

ALX Oncology Holdings Inc. (ALXO) cash flow statement — 8-year operating, investing & financing cash flows

Metric	Q2'26	Q1'26	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24	Q2'24	Q1'24	Q4'23	Q3'23	Q2'23	Q1'23	Q4'22	Q3'22	Q2'22	Q1'22	Q4'21	Q3'21

Cash from Operations	-34.7M	-18.65M	-18.98M	-17.09M	-23.41M	-24.66M	-32.05M	-25.38M	-26.57M	-37.92M	-39.68M	-31.16M	-31.71M	-27.82M	-20.67M	-30.88M	-17M	-20.67M	-17.49M	-24.86M
Operating CF Margin %	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Operating CF Growth %	-48.27%	24.39%	40.77%	32.64%	11.89%	34.97%	19.23%	18.56%	16.22%	-36.34%	-91.98%	-0.89%	-86.56%	-34.55%	-18.18%	-24.25%	17.57%	-302.61%	-28.45%	-160.33%
Net Income	-35.9M	-17.93M	-22.85M	-22.14M	-25.95M	-30.75M	-29.16M	-30.71M	-39.4M	-35.58M	-45.47M	-50.99M	-34.16M	-30.18M	-30.71M	-35.32M	-32.92M	-24.53M	-28.44M	-24.57M
Depreciation & Amortization	236K	150K	151K	153K	191K	211K	214K	224K	220K	214K	207K	209K	513K	213K	413K	397K	280K	376K	34K	6K
Stock-Based Compensation	5.19M	2.51M	2.71M	2.52M	2.14M	5.22M	5.86M	6.95M	7.25M	7.03M	6.72M	6.96M	0	6.35M	0	0	0	0	5.69M	4.19M
Deferred Taxes	0	0	0	0	0	0	0	0	0	0	-11.62M	-1.84M	0	0	0	0	0	0	0	0
Other Non-Cash Items	-1.11M	257K	272K	253K	3.39M	19K	-195K	-523K	-849K	-1.03M	10.15M	372K	4.65M	-748K	5.66M	5.85M	5.83M	5.61M	4.96M	256K
Working Capital Changes	-3.12M	-3.64M	739K	2.12M	-3.17M	645K	-8.76M	-1.32M	6.21M	-8.56M	331K	14.13M	-2.71M	-3.45M	3.97M	-1.81M	9.81M	-2.13M	266K	-4.74M
Change in Receivables	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Change in Inventory	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Change in Payables	-1.98M	-1.21M	-1.67M	1.68M	965K	-556K	-3.78M	-194K	1.88M	-2.33M	-4.48M	8.89M	-5.71M	1.77M	2.45M	-3.06M	3.56M	1.55M	-330K	-2.18M
Cash from Investing	-98.51M	-105.04M	11.23M	21.39M	22.32M	27.64M	33.18M	25.69M	907K	26.47M	-16.67M	12.81M	6.21M	42.3M	10.94M	13.7M	-76.13M	-183.92M	-4.52M	-398K
Capital Expenditures	-67K	-50K	-49K	-56K	-47K	-60K	-60K	-149K	-90K	-148K	-148K	1.3M	-1.74M	-690K	-389K	-192K	-257K	-589K	-261K	-398K
CapEx % of Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Acquisitions	0	0	0	0	0	0	0	0	0	0	50.94K	0	0	0	0	0	0	0	0	0
Investments	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Other Investing	44K	0	0	0	0	0	0	0	0	0	-50.94K	0	0	0	0	0	0	0	-4.26M	0
Cash from Financing	139.73M	139.59M	678K	-159K	-222K	65K	328K	251K	27.15M	3.09M	59.17M	-111K	343K	-107K	9.49M	-136K	422K	80K	524K	439K
Debt Issued (Net)	6.85M	-1.61M	-660K	-160K	-237K	-307K	-76K	-358K	-218K	-175K	-63K	-111K	-107K	-107K	9.24M	-141K	-35K	-105K	-104K	-104K
Equity Issued (Net)	150.79M	141.21M	1.34M	1K	15K	372K	-29.3M	75K	26.2M	3.02M	59.23M	0	450K	0	256K	5K	457K	185K	-103K	0
Dividends Paid	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Share Repurchases	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Other Financing	-17.91M	0	0	0	0	0	29.71M	534K	1.17M	237K	0	0	0	0	0	0	0	0	731K	543K
Net Change in Cash	6.51M	15.91M	-7.07M	4.14M	-1.31M	3.05M	1.47M	568K	1.49M	-8.37M	2.82M	-18.45M	-25.16M	14.37M	-232K	-17.32M	-92.71M	-204.58M	-21.48M	-24.82M
Free Cash Flow	-34.77M	-18.7M	-19.03M	-17.15M	-23.45M	-24.72M	-32.11M	-25.52M	-26.66M	-38.07M	-39.83M	-29.86M	-33.45M	-28.51M	-21.06M	-31.07M	-17.25M	-21.26M	-22.01M	-25.25M
FCF Margin %	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
FCF Growth %	-48.26%	24.37%	40.73%	32.81%	12.02%	35.06%	19.38%	14.51%	20.31%	-33.56%	-89.13%	3.92%	-93.86%	-34.06%	4.31%	-23.05%	16.33%	-313.52%	-61.5%	-164.22%
FCF per Share	-0.26	-0.34	-0.35	-0.32	-0.44	-0.46	-0.61	-0.48	-0.51	-0.76	-0.81	-0.73	-0.82	-0.70	-0.52	-0.76	-0.42	-0.52	-0.54	-0.63
FCF Conversion (FCF/Net Income)	1.93x	1.04x	0.83x	0.77x	0.90x	0.80x	1.10x	0.83x	0.67x	1.07x	0.87x	0.61x	0.93x	0.92x	0.67x	0.87x	0.52x	0.84x	0.61x	1.01x
Interest Paid	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	4K	4K
Taxes Paid	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0